Skip to content
healthcare.dev

Oxymorphone Hydrochloride

NDC 13107-103, Oxymorphone Hydrochloride, tablet, from Aurolife Pharma, LLC.

Product NDC
13107-103
Status
Listed
Labeler
Aurolife Pharma, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204459
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13107-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OXYMORPHONE HYDROCHLORIDE5 mg/1

Pharmacologic classes

Full Opioid Agonists [MoA]; Opioid Agonist [EPC]

Package NDCNDC-11Package
13107-103-0113107010301100 TABLET in 1 BOTTLE (13107-103-01)
13107-103-301310701033030 TABLET in 1 BOTTLE (13107-103-30)
13107-103-99131070103991000 TABLET in 1 BOTTLE (13107-103-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/22c7652a-aa16-4fa8-89d9-517e69059068

Use it

Look up 13107-103 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13107-103 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13107-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.